Hepatitis B and D virus entry

Hepatitis B virus (HBV) entry is the initial step of viral infection, leading to the formation of covalently closed circular DNA, which is a molecular reservoir of viral persistence and a key obstacle for HBV cure. The restricted entry of HBV into specific cell types determines the nature of HBV, wh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature reviews. Microbiology 2024-11
Hauptverfasser: Watashi, Koichi, Shionoya, Kaho, Kobayashi, Chisa, Morita, Takeshi
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Nature reviews. Microbiology
container_volume
creator Watashi, Koichi
Shionoya, Kaho
Kobayashi, Chisa
Morita, Takeshi
description Hepatitis B virus (HBV) entry is the initial step of viral infection, leading to the formation of covalently closed circular DNA, which is a molecular reservoir of viral persistence and a key obstacle for HBV cure. The restricted entry of HBV into specific cell types determines the nature of HBV, which has a narrow host range in tissues and species. Hepatitis D virus (HDV) shares viral surface antigens with HBV and thus follows a similar entry mechanism at its early stages. In late 2012, sodium taurocholate cotransporting polypeptide was discovered as an HBV and HDV entry receptor. Since then, the mechanisms of HBV and HDV entry have been extensively analysed. These analyses have expanded our understanding of HBV and HDV host tropism and have provided new strategies for the development of antiviral agents. Notably, the structures of sodium taurocholate cotransporting polypeptide and its interaction with the 2-48 amino acid region of viral preS1 have been recently solved. These findings will stimulate further entry studies. In this Review, we summarize current understanding of HBV and HDV entry and future perspectives.
doi_str_mv 10.1038/s41579-024-01121-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3131851314</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3131851314</sourcerecordid><originalsourceid>FETCH-LOGICAL-c184t-f0a70ab1ee06ba61546a6b2346552a1ca79f8ac4ea66bef0365d3e3454ea80f13</originalsourceid><addsrcrecordid>eNo9kM1Lw0AQxRdRbK3-A4KSo5fVmf1KctT6UaHgRc_LJJlAJE3rbiL0vzfa2su84fHeO_yEuES4RdDZXTRo01yCMhIQFUp1JKaYGpBotTk-_MpNxFmMnwDK2lSdionOR80MTMXVgjfUN30Tk4eEuip5TL6bMMSEuz5sz8VJTW3ki73OxMfz0_t8IZdvL6_z-6UsMTO9rIFSoAKZwRXk0BpHrlDaOGsVYUlpXmdUGibnCq5BO1tp1saOTgY16pm42e1uwvpr4Nj7VRNLblvqeD1Er1FjZsdjxqjaRcuwjjFw7TehWVHYegT_i8XvsPgRi__D4tVYut7vD8WKq0Pln4P-ASO1Wws</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3131851314</pqid></control><display><type>article</type><title>Hepatitis B and D virus entry</title><source>Nature</source><source>Alma/SFX Local Collection</source><creator>Watashi, Koichi ; Shionoya, Kaho ; Kobayashi, Chisa ; Morita, Takeshi</creator><creatorcontrib>Watashi, Koichi ; Shionoya, Kaho ; Kobayashi, Chisa ; Morita, Takeshi</creatorcontrib><description>Hepatitis B virus (HBV) entry is the initial step of viral infection, leading to the formation of covalently closed circular DNA, which is a molecular reservoir of viral persistence and a key obstacle for HBV cure. The restricted entry of HBV into specific cell types determines the nature of HBV, which has a narrow host range in tissues and species. Hepatitis D virus (HDV) shares viral surface antigens with HBV and thus follows a similar entry mechanism at its early stages. In late 2012, sodium taurocholate cotransporting polypeptide was discovered as an HBV and HDV entry receptor. Since then, the mechanisms of HBV and HDV entry have been extensively analysed. These analyses have expanded our understanding of HBV and HDV host tropism and have provided new strategies for the development of antiviral agents. Notably, the structures of sodium taurocholate cotransporting polypeptide and its interaction with the 2-48 amino acid region of viral preS1 have been recently solved. These findings will stimulate further entry studies. In this Review, we summarize current understanding of HBV and HDV entry and future perspectives.</description><identifier>ISSN: 1740-1526</identifier><identifier>ISSN: 1740-1534</identifier><identifier>EISSN: 1740-1534</identifier><identifier>DOI: 10.1038/s41579-024-01121-2</identifier><identifier>PMID: 39572840</identifier><language>eng</language><publisher>England</publisher><ispartof>Nature reviews. Microbiology, 2024-11</ispartof><rights>2024. Springer Nature Limited.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c184t-f0a70ab1ee06ba61546a6b2346552a1ca79f8ac4ea66bef0365d3e3454ea80f13</cites><orcidid>0000-0002-4536-9966</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39572840$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Watashi, Koichi</creatorcontrib><creatorcontrib>Shionoya, Kaho</creatorcontrib><creatorcontrib>Kobayashi, Chisa</creatorcontrib><creatorcontrib>Morita, Takeshi</creatorcontrib><title>Hepatitis B and D virus entry</title><title>Nature reviews. Microbiology</title><addtitle>Nat Rev Microbiol</addtitle><description>Hepatitis B virus (HBV) entry is the initial step of viral infection, leading to the formation of covalently closed circular DNA, which is a molecular reservoir of viral persistence and a key obstacle for HBV cure. The restricted entry of HBV into specific cell types determines the nature of HBV, which has a narrow host range in tissues and species. Hepatitis D virus (HDV) shares viral surface antigens with HBV and thus follows a similar entry mechanism at its early stages. In late 2012, sodium taurocholate cotransporting polypeptide was discovered as an HBV and HDV entry receptor. Since then, the mechanisms of HBV and HDV entry have been extensively analysed. These analyses have expanded our understanding of HBV and HDV host tropism and have provided new strategies for the development of antiviral agents. Notably, the structures of sodium taurocholate cotransporting polypeptide and its interaction with the 2-48 amino acid region of viral preS1 have been recently solved. These findings will stimulate further entry studies. In this Review, we summarize current understanding of HBV and HDV entry and future perspectives.</description><issn>1740-1526</issn><issn>1740-1534</issn><issn>1740-1534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kM1Lw0AQxRdRbK3-A4KSo5fVmf1KctT6UaHgRc_LJJlAJE3rbiL0vzfa2su84fHeO_yEuES4RdDZXTRo01yCMhIQFUp1JKaYGpBotTk-_MpNxFmMnwDK2lSdionOR80MTMXVgjfUN30Tk4eEuip5TL6bMMSEuz5sz8VJTW3ki73OxMfz0_t8IZdvL6_z-6UsMTO9rIFSoAKZwRXk0BpHrlDaOGsVYUlpXmdUGibnCq5BO1tp1saOTgY16pm42e1uwvpr4Nj7VRNLblvqeD1Er1FjZsdjxqjaRcuwjjFw7TehWVHYegT_i8XvsPgRi__D4tVYut7vD8WKq0Pln4P-ASO1Wws</recordid><startdate>20241121</startdate><enddate>20241121</enddate><creator>Watashi, Koichi</creator><creator>Shionoya, Kaho</creator><creator>Kobayashi, Chisa</creator><creator>Morita, Takeshi</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4536-9966</orcidid></search><sort><creationdate>20241121</creationdate><title>Hepatitis B and D virus entry</title><author>Watashi, Koichi ; Shionoya, Kaho ; Kobayashi, Chisa ; Morita, Takeshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c184t-f0a70ab1ee06ba61546a6b2346552a1ca79f8ac4ea66bef0365d3e3454ea80f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Watashi, Koichi</creatorcontrib><creatorcontrib>Shionoya, Kaho</creatorcontrib><creatorcontrib>Kobayashi, Chisa</creatorcontrib><creatorcontrib>Morita, Takeshi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nature reviews. Microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Watashi, Koichi</au><au>Shionoya, Kaho</au><au>Kobayashi, Chisa</au><au>Morita, Takeshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hepatitis B and D virus entry</atitle><jtitle>Nature reviews. Microbiology</jtitle><addtitle>Nat Rev Microbiol</addtitle><date>2024-11-21</date><risdate>2024</risdate><issn>1740-1526</issn><issn>1740-1534</issn><eissn>1740-1534</eissn><abstract>Hepatitis B virus (HBV) entry is the initial step of viral infection, leading to the formation of covalently closed circular DNA, which is a molecular reservoir of viral persistence and a key obstacle for HBV cure. The restricted entry of HBV into specific cell types determines the nature of HBV, which has a narrow host range in tissues and species. Hepatitis D virus (HDV) shares viral surface antigens with HBV and thus follows a similar entry mechanism at its early stages. In late 2012, sodium taurocholate cotransporting polypeptide was discovered as an HBV and HDV entry receptor. Since then, the mechanisms of HBV and HDV entry have been extensively analysed. These analyses have expanded our understanding of HBV and HDV host tropism and have provided new strategies for the development of antiviral agents. Notably, the structures of sodium taurocholate cotransporting polypeptide and its interaction with the 2-48 amino acid region of viral preS1 have been recently solved. These findings will stimulate further entry studies. In this Review, we summarize current understanding of HBV and HDV entry and future perspectives.</abstract><cop>England</cop><pmid>39572840</pmid><doi>10.1038/s41579-024-01121-2</doi><orcidid>https://orcid.org/0000-0002-4536-9966</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1740-1526
ispartof Nature reviews. Microbiology, 2024-11
issn 1740-1526
1740-1534
1740-1534
language eng
recordid cdi_proquest_miscellaneous_3131851314
source Nature; Alma/SFX Local Collection
title Hepatitis B and D virus entry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T06%3A55%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hepatitis%20B%20and%20D%20virus%20entry&rft.jtitle=Nature%20reviews.%20Microbiology&rft.au=Watashi,%20Koichi&rft.date=2024-11-21&rft.issn=1740-1526&rft.eissn=1740-1534&rft_id=info:doi/10.1038/s41579-024-01121-2&rft_dat=%3Cproquest_cross%3E3131851314%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3131851314&rft_id=info:pmid/39572840&rfr_iscdi=true